NVCT — NUVECTIS PHARMA INC

Ownership history in XTX Topco Ltd  ·  1 quarter on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in NUVECTIS PHARMA INC (NVCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 14,866 — — 0.00% $89K $6.02
% of Fund (quarterly)    NVCT price (monthly, adj. close)

Other funds also holding NVCT

As of 2025 Q4 — sorted by position size

IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 1.63% BALDWIN WEALTH PARTNERS LLC/MA 3Y 7Y 0.19% FORBES J M & CO LLP 3Y 7Y 0.04% Austin Wealth Management, LLC 0.03% OPPENHEIMER & CO INC 3Y 7Y 0.01% NATIONS FINANCIAL GROUP INC, /IA/ /ADV 3Y 7Y 0.01% NBC SECURITIES, INC. 0.0% EDMOND DE ROTHSCHILD HOLDING S.A. 3Y 7Y 0.0% Ameritas Investment Partners, Inc. 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings